Home / Intelligence / Briefs / 2025 Annual State of Learning & Development in Life Sciences
Through the 2020s, life sciences leaders have dealt with one challenge after another. The shock of the COVID-19 pandemic. Sticky inflation. Return-to-office mandates. The intense pressure to perform in the face of disruptive challenges has proven constant.
For commercial learning and development, also known as commercial L&D, this has presented new roadblocks and innovations alike, making data more important than ever to navigate a rapidly changing industry. That’s why TGaS Advisors, a Division of Trinity Life Sciences, in partnership with the Life Sciences Trainers & Educators Network (LTEN), conducted this study.
The 2025 Annual State of L&D in Life Sciences: Essentials for High-Performing Learning Organizations assesses the current landscape of commercial L&D and benchmarks performance across organizations. This is part one of a three-part series in empowering the data-driven learning leader. The study features survey responses from 56 heads of commercial L&D from 39 unique life sciences organizations. Organizations that had more than one response had more than one commercial L&D function.
Complete the form below to access the advisory brief.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Related Intelligence
Briefs
Leading the Evolution: Navigating AI and Pharma Market Trends
How are Commercial, Medical and Market Access organizations evolving to develop capabilities and accelerate innovation in 2025 and beyond? Executive leaders are focused on making informed organizational decisions to propel the evolution of capabilities in this rapidly changing global economy. As you strategize to optimize structure, talent and capabilities to excel in the future, this Advisory Brief brings you critical insights gleaned from the recent TGaS Advisors’ 2025 Spring Summit.
Read More
Blog
Is Medical Omnichannel Poised for Growth?
79% of respondents are predicting an increase in spend in Omnichannel capabilities for Medical Affairs in 2025, according to a recent TGaS survey fielded in September 2024.* This predicted increase for Medical Omnichannel indicates that there is a real need to find ways to inform, educate and engage HCPs beyond the traditional in-person channel. What […]
Read More
Briefs
2024 Annual Digital Marketing Competency Report
Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 150+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a […]
Read More